Media
Latest News
Washington, D.C. - Today, Congressman Chris Pappas (NH-01), member of the House Veterans Affairs Committee and Co-Chair of the Equality Caucus, alongside Reps. Mike Levin (CA-49), Kathleen M.
Today, Congressman Chris Pappas (NH-01) released the following statement after the Supreme Court failed to stop a Texas abortion ban from taking effect early this morning:
Yesterday, Congressman Chris Pappas (NH-01) reintroduced the bipartisan Expanding Access to Rural Job Creators Act alongside Congresswoman Cindy Axne (IA-03) to help small businesses and rural entrepreneurs across New Hampshire.
Washington, D.C. - Today, Congressman Chris Pappas, a member of the House Veterans Affairs Committee and Chair of the Subcommittee on Oversight and Investigations for the House Committee on Veterans' Affairs issued the following statement after the Bide
Manchester, NH - Following the news of an explosion outside the Kabul airport, Congressman Chris Pappas released the following statement:
Washington, D.C. - Today, Congressman Chris Pappas (NH-01) released the following statement following the passage of H.R. 4, the John R. Lewis Voting Rights Advancement Act:
Today, Congressman Chris Pappas (NH-01) led 63 lawmakers in calling on Secretary of State Antony Blinken to expand the Department of State's recently announced Priority 2 designation granting U.S.
Today, Congressman Chris Pappas (NH-01) released the following statement after the House voted to advance the bipartisan infrastructure package and the budget resolution:
Congressman Chris Pappas (NH-01) released the following statement urging the Biden Administration to remain in Kabul as long as possible to evacuate Americans, SIV applicants, and other Afghan allies who are now in danger of retribution from the Taliban.
Portsmouth, NH – Earlier this month, Congressman Chris Pappas (NH-01) joined with Novocure leadership to tour their facility in Portsmouth to learn more about their vital work of striving to extend survival in some of the most aggressive forms of cancer through the development and commercialization of Novocure's innovati